Semaglutide is a medication used for both the treatment of type 2 diabetes and for long-term weight management in adults with obesity
Early controlled trials showed promise in schizophrenia, for cognition, psychotic symptoms, and extrapyramidal side effects, and this trial adds to that limited database
Kidney Problems Mounjaro can cause kidney problems, particularly in patients with pre-existing kidney conditions
GSIS values were calculated from the luminescence intensity ratio at high (28 mM) to low (5.6 mM) glucose concentrations
3D variability of these GLP-1R complexes was analysed in 5 motions and the 20 volume frame data in each motion was generated in cryoSPARC(Punjani et al
How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted